Pulmonary embolism in intensive care units: More frequent or more Known? Prospective study of 75 cases.


Journal

The clinical respiratory journal
ISSN: 1752-699X
Titre abrégé: Clin Respir J
Pays: England
ID NLM: 101315570

Informations de publication

Date de publication:
Aug 2019
Historique:
received: 10 08 2018
revised: 15 01 2019
accepted: 01 07 2019
pubmed: 10 7 2019
medline: 11 2 2020
entrez: 10 7 2019
Statut: ppublish

Résumé

to evaluate the current rate of pulmonary embolism (PE) in our medico-surgical intensive care unit (ICU), to identify risk factors, and to determine the outcome of PE in ICU. We performed a prospective cohort study of consecutive patients requiring intensive care admission during a one-year period. We included, in this prospective study, all the patients with confirmed PE admitted in ICU with more than 18 years of age, and expected to stay in ICU for more than 48 hours. Only the patients who had a clinical suspicion (unexplained hypoxemia and/or shock) for PE underwent diagnostic studies. During the study period, 842 patients were admitted in our ICU. One hundred and two patients were excluded. The diagnosis of PE was confirmed in 75 patients (10.1%). In our study, all patients (100%) had received some forms of pharmaceutical prophylaxis (PP) during ICU stay. The median time from ICU admission to diagnosis of PE was 6 days. The diagnosis of PE was made by spiral CT in 74 patients (98.7%), and by echocardiography in 1 case (1.3%). The mean ICU stay was 26.3 ± 26.5 days (median: 20 days). During their ICU stay, 73 patients (97.3%) developed one, or more, organ failure. Respiratory failure was the most observed (97.3%). Moreover, 38 patients (50.6%) developed nosocomial infections and 29 (38.6%) died. The multivariate analysis showed that the risk factors associated with mortality were the presence of shock the day of PE diagnosis and the presence of right ventricular dilatation on echocardiography. Our findings confirm that subjects in the ICU are at high risk of PE, due to a high number of risk-factors. PE was associated with higher ICU mortality and a significantly higher ICU LOS. Our results invite to revise the preventive strategies of deep venous thrombosis and PE in patients requiring ICU admission.

Identifiants

pubmed: 31287237
doi: 10.1111/crj.13053
doi:

Types de publication

Comparative Study Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

513-520

Informations de copyright

© 2019 John Wiley & Sons Ltd.

Auteurs

Mabrouk Bahloul (M)

Department of Intensive Care, Habib Bourguiba University Hospital, Sfax, Tunisia.
Faculté de medicine de Sfax, Sfax University, Sfax, Tunisia.

Kais Regaieg (K)

Department of Intensive Care, Habib Bourguiba University Hospital, Sfax, Tunisia.
Faculté de medicine de Sfax, Sfax University, Sfax, Tunisia.

Mariem Dlela (M)

Department of Intensive Care, Habib Bourguiba University Hospital, Sfax, Tunisia.
Faculté de medicine de Sfax, Sfax University, Sfax, Tunisia.

Olfa Turki (O)

Department of Intensive Care, Habib Bourguiba University Hospital, Sfax, Tunisia.
Faculté de medicine de Sfax, Sfax University, Sfax, Tunisia.

Hana Nouri (H)

Department of Intensive Care, Habib Bourguiba University Hospital, Sfax, Tunisia.
Faculté de medicine de Sfax, Sfax University, Sfax, Tunisia.

Sabrine Bradaii (S)

Department of Intensive Care, Habib Bourguiba University Hospital, Sfax, Tunisia.
Faculté de medicine de Sfax, Sfax University, Sfax, Tunisia.

Chokri Ben Hamida (C)

Department of Intensive Care, Habib Bourguiba University Hospital, Sfax, Tunisia.
Faculté de medicine de Sfax, Sfax University, Sfax, Tunisia.

Nadia Khlaf Bouaziz (NK)

Centre Intermédiaire, Rte El MATAR Km 4, Sfax, Tunisia.

Imen Chabchoub (I)

Department of Pediatrics Hedi Chaker University Hospital, Sfax University, Sfax, Tunisia.

Sondes Haddar (S)

Department of Radiology Habib Bourguiba University Hospital, Sfax University, Sfax, Tunisia.

Hedi Chelly (H)

Department of Intensive Care, Habib Bourguiba University Hospital, Sfax, Tunisia.
Faculté de medicine de Sfax, Sfax University, Sfax, Tunisia.

Mounir Bouaziz (M)

Department of Intensive Care, Habib Bourguiba University Hospital, Sfax, Tunisia.
Faculté de medicine de Sfax, Sfax University, Sfax, Tunisia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH